Abstract

Objectives: Fine needle aspiration (FNA) with cytological analysis is an initial step in investigating thyroid nodules. We systematically reviewed the diagnostic value of adding B-type Raf kinase (BRAFV600E) gene mutation analysis to the conventional FNA in the diagnosis of papillary thyroid cancer (PTC). Methods: Studies reporting BRAFV600E mutation analysis following FNA for evaluation of thyroid nodules were identified through searching electronic databases (eg, MEDLINE, EMBASE) through 1948-2011, scanning reference lists of relevant studies, and contacting experts. Two independent reviewers screened literature results, abstracted data, and appraised study quality. Meta-analysis of sensitivity and specificity was performed using bivariate random effects models. Results: Forty-two studies met our inclusion criteria after screening 787 citations and 117 full-text articles. The included studies enrolled approximately 7,676 patients with 8,196 FNA samples evaluated for BRAFV600E mutation. Bivariate-pooled sensitivity and specificity results from 29 included studies that examined BRAFV600E mutation among cytologically confirmed PTC samples were 72.6% (95% confidence interval [CI] 66.1-78.3%) and 50.8% (95% CI; 32.3-69.1%), respectively. For samples that were diagnosed cytologically as suspicious for PTC, and confirmed by histology as PTC, bivariate-pooled sensitivity and specificity results were 52.1% (95% CI; 36.3-67.4%) and 85.3% (95% CI; 55.2-96.5%), respectively. Eleven studies reported non-diagnostic FNA samples. The pooled sensitivity and specificity results for these samples were 50.5% (95% Cl; 31-69.8%) and 92.9% (95% Cl; 74.2-98.3%), respectively. Conclusions: BRAFV600E mutation analysis is associated with increase specificity and moderate increase in the sensitivity of FNA in the diagnosis of papillary thyroid cancer.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call